Status:
COMPLETED
Inspiratory Muscle Trainer and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) COVID-19 Persistent Symptoms
Lead Sponsor:
Cairo University
Conditions:
Covid19
Hypertension
Eligibility:
MALE
40-60 years
Phase:
NA
Brief Summary
Inspiratory muscle training considered as safe and valid method to improve respiratory muscle strength and functional capacity among uncountable conditions which could improve post COVID-19 persistent...
Detailed Description
The current COVID-19 pandemic will place enormous pressure on healthcare systems around the world. The COVID-19 pandemic continues to dominate our daily lives with large numbers of people are predicte...
Eligibility Criteria
Inclusion
- sixty non hospitalized negative post covid-19
- men
- cigarette smokers
- 40-60 years old
- stage II Hypertensive (160-179 / 100-109 mmHg)
- Oxygen saturation less than 94%
- Severity of disease (Moderate Covid-19 affection)
- Body mass index (BMI) ranged from 25 to 29.9 kg/m2
- hemodynamically stable
- at least 4 weeks since first COVID-19 swab at time of screening
Exclusion
- Patients with red flag indicators as chest pain, critical drop of oxygen saturation which require oxygen supply, severe level of hypoxia (blue lips)
- Unconscious patient
- Positive covid-19 patients
- Patients with cognitive impairment
- End-stage of chronic diseases
- BMI more than 30 kg/m2
- History of other cardiovascular disease as coronary artery disease, valvular heart disease, cardiac arrhythmias, congestive heart failure, myocardial infarction, stroke, transient ischemic attack, or peripheral vascular disease
- Neurological, neuromuscular, and musculoskeletal limitations
- Current active infection
- Developmental disability or cognitive impairment that in the opinion of the investigator would preclude adequate comprehension of the informed consent form and/or ability to record the necessary study measurements.
- Participation in a clinical study or other type of research in the past 30 days
Key Trial Info
Start Date :
August 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04919031
Start Date
August 1 2021
End Date
December 1 2022
Last Update
February 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Physical Therapy
Giza, Dokki, Egypt, 11432